C91.31
Prolymphocytic leukemia of B-cell type, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Prolymphocytic leukemia (PLL) of B-cell type is a rare form of blood cancer that affects the lymphatic system. When this disease enters remission, it means that signs and symptoms have decreased significantly or disappeared following treatment. This guide provides an overview of this condition, highlighting its causes, symptoms, diagnosis, and treatment options.
Causes & Symptoms
Clinical Causes: Genetic abnormalities or mutations in lymphoid cells Age-related changes, as the condition is more common in older adults Previous history of other blood disorders or cancers Environmental exposures, such as exposure to certain chemicals or radiation (though evidence is limited) Family history of hematologic malignancies
Key Symptoms: Enlarged lymph nodes, especially in the neck, armpits, or groin Splenomegaly (enlarged spleen) Persistent fatigue or weakness Unexplained weight loss Fever or night sweats Frequent infections due to impaired immune function Easy bruising or bleeding Shortness of breath or discomfort due to enlarged organs
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC) to evaluate blood cell levels Peripheral blood smear to observe the appearance of lymphocytes Flow cytometry to identify specific cell surface markers characteristic of B-cell lymphoma Bone marrow biopsy to assess marrow involvement Imaging studies, such as ultrasound or CT scans, to evaluate organ size Genetic testing to detect mutations associated with the disease
Treatment Protocols: Observation or 'watchful waiting' in cases where the disease is asymptomatic and stable Chemotherapy to eliminate cancerous cells Targeted therapies that specifically attack abnormal B-cell lymphocytes Immunotherapy, which boosts the body's natural defenses Splenectomy or removal of enlarged spleen in some cases Supportive care, such as blood transfusions or antibiotics for infections
Clinical Advice & FAQs
Billing Guidance
Is C91.31 a billable ICD-10 code?
Yes, C91.31 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C91.31?
Clinical documentation must specify the nature of Prolymphocytic leukemia of B-cell type, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference